Facebook
X
LinkedIn
ForwardAsian Clinical Aesthetic Innovations Conference
June 27, 2026
The Asian Clinical Aesthetics Innovation Conference is a live, in-person educational activity designed to advance clinical knowledge and practice in dermatology, with an integrated focus on aesthetic applications. This boutique scientific meeting brings together global experts to discuss emerging evidence, clinical advancements, and evolving therapeutic strategies across medical, surgical, and cosmetic dermatology.
The program features expert-led sessions addressing a wide spectrum of dermatologic conditions including inflammatory skin diseases, pigmentary disorders, alopecia, psoriasis, eczema, vitiligo, and scarring, alongside advancements in procedural and aesthetic dermatology.
Through interactive panels, and evidence-driven presentations, participants will gain practical insights into integrating novel therapies, optimizing patient outcomes, and applying safe and effective treatment strategies in diverse patient populations, including skin of color.
Target Audience
This activity is designed for dermatologists, dermatologic surgeons, and other healthcare professionals involved in the clinical management of skin diseases. The target audience includes clinicians with an interest in medical, surgical, and aesthetic dermatology, including those engaged in the diagnosis and treatment of inflammatory skin disorders, pigmentary conditions, alopecia, and other dermatologic diseases. The program is also relevant to physicians and clinical researchers seeking to integrate emerging therapies, procedural techniques, and evidence-based innovations into dermatologic practice, particularly in diverse patient populations and skin of color.
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Evaluate emerging evidence and evolving treatment strategies for common and complex dermatologic conditions including psoriasis, eczema, alopecia, and pigmentary disorders.
- Apply updated clinical approaches to the diagnosis and management of skin diseases, incorporating patient-specific factors and advances in therapeutics.
- Integrate aesthetic and procedural dermatology techniques, including lasers, energy-based devices, and injectables, into comprehensive clinical practice.
- Assess the role of novel technologies, regenerative therapies, and emerging research in improving dermatologic care and patient outcomes.
- Recognize differences in skin biology and disease presentation in diverse populations, particularly in skin of color, to optimize safe and effective treatment strategies.
New York City, NY
United States
Committee Member, Planner, Staff(s)
Michael Gold, M.D.
has a financial relationship (Consultant) with Acclaro;.
has a financial relationship (Consultant) with Advalight;.
has a financial relationship (Consultant) with Aerolase;.
has a financial relationship (Consultant) with Aesthetic Management Partners;.
has a financial relationship (Consultant) with Alastin/Galderma;.
has a financial relationship (Consultant) with Allergan Aesthetics/AbbVie;.
has a financial relationship (Consultant) with Alma Lasers;.
has a financial relationship (Consultant) with Bausch Health/Solta;.
has a financial relationship (Researcher) with Bausch Health/Solta;.
has a financial relationship (Consultant) with Benev;.
has a financial relationship (Consultant) with Croma;.
has a financial relationship (Researcher) with Benev;.
has a financial relationship (Researcher) with Croma;.
has a financial relationship (Consultant) with Cutera;.
has a financial relationship (Consultant) with EndyMed;.
has a financial relationship (Consultant) with ExocoBio;.
has a financial relationship (Consultant) with Hugel;.
has a financial relationship (Researcher) with Hugel;.
has a financial relationship (Consultant) with IBSA;.
has a financial relationship (Researcher) with IBSA;.
has a financial relationship (Consultant) with InMode;.
has a financial relationship (Consultant) with La Mer;.
has a financial relationship (Consultant) with Leo Pharma;.
has a financial relationship (Consultant) with Lumenis;.
has a financial relationship (Researcher) with Leo Pharma;.
has a financial relationship (Researcher) with Lumenis;.
has a financial relationship (Consultant) with Merz;.
has a financial relationship (Researcher) with Merz;.
has a financial relationship (Consultant) with MTF;.
has a financial relationship (Researcher) with MTF;.
has a financial relationship (Researcher) with Nordberg Medical;.
has a financial relationship (Consultant) with Nutrafol;.
has a financial relationship (Consultant) with Pierre Fabre/Glytone;.
has a financial relationship (Consultant) with Prescriber's Choice;.
has a financial relationship (Consultant) with Revance/Crown;.
has a financial relationship (Researcher) with Revance/Crown;.
has a financial relationship (Consultant) with Revision Skin Care;.
has a financial relationship (Researcher) with Revision Skin Care;.
has a financial relationship (Consultant) with Sciton;.
has a financial relationship (Consultant) with Sensus Healthcare;.
has a financial relationship (Consultant) with Skinbetter Science;.
has a financial relationship (Researcher) with Skinbetter Science;.
has a financial relationship (Consultant) with SkinCeuticals;.
has a financial relationship (Consultant) with Skin Medica;.
has a financial relationship (Consultant) with Sofwave;.
has a financial relationship (Researcher) with Sofwave;.
has a financial relationship (Consultant) with Stratpharma;.
has a financial relationship (Researcher) with Stratpharma;.
has a financial relationship (Consultant) with Strata Skin Sciences;.
has a financial relationship (Consultant) with Venus Concept;.
has a financial relationship (Researcher) with Venus Concept;.
has a financial relationship (Consultant) with VIOL;.
has a financial relationship (Consultant) with Vydence;.
Mukta Sachdev, Medical Director, MS Clinical Research Pvt. Ltd.; HOD & Consultant, Dermatology, Manipal Hospital, Bangalore, India
has no relevant financial relationships to disclose at this time.
Jane Yoo, MD, MPP
has no relevant financial relationships to disclose at this time.
Reviewer(s)
Rebecca Lakofsky, BSN, RN
has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)
Suephy Chen, MD, MS
has a financial relationship (Royalties or patent beneficiary) with Norvtis;.
Michael Gold, M.D.
has a financial relationship (Consultant) with Acclaro;.
has a financial relationship (Consultant) with Advalight;.
has a financial relationship (Consultant) with Aerolase;.
has a financial relationship (Consultant) with Aesthetic Management Partners;.
has a financial relationship (Consultant) with Alastin/Galderma;.
has a financial relationship (Consultant) with Allergan Aesthetics/AbbVie;.
has a financial relationship (Consultant) with Alma Lasers;.
has a financial relationship (Consultant) with Bausch Health/Solta;.
has a financial relationship (Researcher) with Bausch Health/Solta;.
has a financial relationship (Consultant) with Benev;.
has a financial relationship (Consultant) with Croma;.
has a financial relationship (Researcher) with Benev;.
has a financial relationship (Researcher) with Croma;.
has a financial relationship (Consultant) with Cutera;.
has a financial relationship (Consultant) with EndyMed;.
has a financial relationship (Consultant) with ExocoBio;.
has a financial relationship (Consultant) with Hugel;.
has a financial relationship (Researcher) with Hugel;.
has a financial relationship (Consultant) with IBSA;.
has a financial relationship (Researcher) with IBSA;.
has a financial relationship (Consultant) with InMode;.
has a financial relationship (Consultant) with La Mer;.
has a financial relationship (Consultant) with Leo Pharma;.
has a financial relationship (Consultant) with Lumenis;.
has a financial relationship (Researcher) with Leo Pharma;.
has a financial relationship (Researcher) with Lumenis;.
has a financial relationship (Consultant) with Merz;.
has a financial relationship (Researcher) with Merz;.
has a financial relationship (Consultant) with MTF;.
has a financial relationship (Researcher) with MTF;.
has a financial relationship (Researcher) with Nordberg Medical;.
has a financial relationship (Consultant) with Nutrafol;.
has a financial relationship (Consultant) with Pierre Fabre/Glytone;.
has a financial relationship (Consultant) with Prescriber's Choice;.
has a financial relationship (Consultant) with Revance/Crown;.
has a financial relationship (Researcher) with Revance/Crown;.
has a financial relationship (Consultant) with Revision Skin Care;.
has a financial relationship (Researcher) with Revision Skin Care;.
has a financial relationship (Consultant) with Sciton;.
has a financial relationship (Consultant) with Sensus Healthcare;.
has a financial relationship (Consultant) with Skinbetter Science;.
has a financial relationship (Researcher) with Skinbetter Science;.
has a financial relationship (Consultant) with SkinCeuticals;.
has a financial relationship (Consultant) with Skin Medica;.
has a financial relationship (Consultant) with Sofwave;.
has a financial relationship (Researcher) with Sofwave;.
has a financial relationship (Consultant) with Stratpharma;.
has a financial relationship (Researcher) with Stratpharma;.
has a financial relationship (Consultant) with Strata Skin Sciences;.
has a financial relationship (Consultant) with Venus Concept;.
has a financial relationship (Researcher) with Venus Concept;.
has a financial relationship (Consultant) with VIOL;.
has a financial relationship (Consultant) with Vydence;.
David Goldberg
has a financial relationship (Independent contractor (including contracted research)) with Sofwave;.
has a financial relationship (Independent contractor (including contracted research)) with Absci;.
has a financial relationship (Independent contractor (including contracted research)) with AMP;.
Richard Granstein, MD; Professor and Chair, Weill Cornell Medicine
has a financial relationship (Researcher) with Pfizer;.
has a financial relationship (Researcher) with Pfizer;.
has a financial relationship (Ownership interest) with Elysium Health;.
has a financial relationship (Advisor) with BelleTorus;.
has a financial relationship (Advisor) with Amorepacific;.
has a financial relationship (Advisor) with Gore Range Capital;.
has a financial relationship (Ownership interest) with Novaestiq;.
George Han, MD, PhD
has a financial relationship (Consultant) with J&J;.
has a financial relationship (Consultant) with UCB;.
has a financial relationship (Consultant) with Sanofi;.
has a financial relationship (Consultant) with Regeneron;.
has a financial relationship (Consultant) with BMS;.
has a financial relationship (Consultant) with SUN Pharmaceuticals;.
has a financial relationship (Consultant) with LEO;.
has a financial relationship (Consultant) with Apogee;.
has a financial relationship (Consultant) with Pfizer;.
Stacy Hawkins
has a financial relationship (Employee) with Unilever R&D;.
Roger Ho, MD, MS, MPH, FAAD
has a financial relationship (Advisor) with Veradermics;.
Carol Huang, MD, FAAD
has no relevant financial relationships to disclose at this time.
TARANNUM JALEEL, MD
has a financial relationship (Researcher) with UCB;.
has a financial relationship (Researcher) with Abbvie;.
has a financial relationship (Researcher) with Sonoma;.
has a financial relationship (Researcher) with Eli Lilly;.
has a financial relationship (Researcher) with Almirall;.
has a financial relationship (Consultant) with Eli Lilly;.
has a financial relationship (Consultant) with UCB;.
has a financial relationship (Consultant) with Novartis;.
Sewon Kang, MD
has a financial relationship (Advisor) with Amorepacific;.
has a financial relationship (Advisor) with Eli Lilly;.
has a financial relationship (Advisor) with Incyte;.
has a financial relationship (Individual stocks and stock options) with Rapalogix;.
has a financial relationship (Advisor) with La Roche-Posay;.
has a financial relationship (Advisor) with Estee Lauder;.
Alice Kim, MBS, GC (Cosmetic Science)
has no relevant financial relationships to disclose at this time.
Jenny Kim
has no relevant financial relationships to disclose at this time.
Wooseok Koh
has a financial relationship (Individual stocks and stock options) with LaserOptek;.
has a financial relationship (Consultant) with Agnes Medical;.
has a financial relationship (Individual stocks and stock options) with JSK Biomed;.
has a financial relationship (Individual stocks and stock options) with Innoxus;.
has a financial relationship (Consultant) with Asterasys;.
Kachiu Lee, MD
has a financial relationship (Speaker) with Skinceuticals;.
has a financial relationship (Researcher) with Merz Aesthetics;.
has a financial relationship (Speaker) with Revance Aesthetics;.
Markham Luke, MD PhD FAAD
has no relevant financial relationships to disclose at this time.
Kavita Mariwalla
has a financial relationship (Consultant) with Estee Lauder;.
has a financial relationship (Royalties or patent beneficiary) with belle.ai;.
has a financial relationship (Consultant) with Boards University;.
has a financial relationship (Researcher) with AbbVie;.
Girish Munavalli, MD
has a financial relationship (Consultant) with Candela;.
Janet OLIVERO
has a financial relationship (Employee) with L'Oreal USA;.
Aiden Park
has no relevant financial relationships to disclose at this time.
Mukta Sachdev, Medical Director, MS Clinical Research Pvt. Ltd.; HOD & Consultant, Dermatology, Manipal Hospital, Bangalore, India
has no relevant financial relationships to disclose at this time.
SUK BAE SEO
has no relevant financial relationships to disclose at this time.
Seaver Soon
has a financial relationship (Advisor) with Beiersdorf, Inc;.
has a financial relationship (Advisor) with CP Skin Health ;.
has a financial relationship (Individual stocks and stock options) with Parallel Health ;.
has a financial relationship (Advisor) with VeraDermics Inc. ;.
has a financial relationship (Advisor) with Medscape;.
Thanh Nga Tran, MD PhD
has a financial relationship (Consultant) with AVAVA, Inc. ;.
has a financial relationship (Consultant) with Amgen;.
Sarah Vickery, Senior Vice President, ESTÉE LAUDER COMPANIES R&I
has a financial relationship (Executive role) with The Estee Lauder Companies;.
Jane Yoo, MD, MPP
has no relevant financial relationships to disclose at this time.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Asian Clinical Aesthetic Innovations. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 6.75 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 6.75 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.